Quick Answer
PDS Biotechnology Corp reported Net Income of -$34.50 million for fiscal year 2025.
PDS Biotechnology Corp Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$34.50M | +8.3% |
| 2024 | -$37.61M | +12.4% |
| 2023 | -$42.94M | -5.1% |
| 2022 | -$40.85M | -141.5% |
| 2021 | -$16.92M | -13.9% |
| 2020 | -$14.85M | -112.1% |
| 2019 | -$7.00M | -82.4% |
| 2018 | -$3.84M | +92.5% |
| 2017 | -$50.86M | -31.0% |
| 2016 | -$38.82M | -38.3% |
| 2015 | -$28.08M | -130.1% |
| 2014 | -$12.20M | -77.3% |
| 2013 | -$6.88M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$9.01M | +16.0% | +4.5% |
| June 30, 2025 | -$9.43M | -13.3% | -11.1% |
| March 31, 2025 | -$8.49M | +19.9% | +20.9% |
| September 30, 2024 | -$10.73M | +1.1% | -28.8% |
| June 30, 2024 | -$8.33M | +27.8% | +21.5% |
| March 31, 2024 | -$10.60M | -9.8% | +2.3% |
| September 30, 2023 | -$10.85M | -46.1% | +5.9% |
| June 30, 2023 | -$11.53M | -98.2% | -19.4% |
- PDS Biotechnology Corp showed an increase of +8.3% in Net Income compared to the prior fiscal year.
- Over the 2013–2025 period, PDS Biotechnology Corp’s net income has declined by 401.2% (from -$6.88 million to -$34.50 million).
- The most recent figure is from PDS Biotechnology Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: